September 3, 2008 - Endologix Inc. yesterday said six-year patient follow-up data from the company’s Powerlink System ...
LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software. The multimodality, Web ...
Cook Medical has received approval from the FDA for its Zenith TX2 Thoracic TAA Endovascular Graft, marking the expansion of Cook Medical’s portfolio of devices to treat aortic diseases.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
St. Jude Medical Inc. recently released its EnSite System Version 8.0, software designed to intuitively visualize the ...
Nihon Kohden America Inc. said its Prefense Early Detection and Notification System received 510(k) clearance from the ...
The process of the coronary CT angiography (CTA) becoming the preferred imaging modality is akin to the process of obtaining a pilot’s license.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
September 4, 2008 – St. Elizabeth, in Cincinnati, OH, which serves more than 300 stroke patients annually, is the first ...
The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s ...
AngioScore Inc. has introduced longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD).
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The R Series defibrillator for hospitals aims for simplicity and operational readiness to help improve in-hospital ...
The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped reduce the number of complications due to debris being released into the bloodstream and causing blockages in smaller vessels. The devices are designed to capture and remove debris that may be dislodged during procedures. There are three classes of EPD devices:
In as much as the environment in which you live can affect your quality of life, so can the environment in which someone receives medical care affect patient outcome – at least in theory.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 3, 2008 - Edwards Lifesciences Corp. today said it received FDA approval for the Carpentier-Edwards PERIMOUNT ...
September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
Edwards Lifesciences Corp. produces the Carpentier-Edwards The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process. September 2008
September 03, 2008
